Morepen Laboratories Ltd.
NSE: MOREPENLAB | BSE: 500288
₹123.87
₹-1.73
(-1.38%)
As on 16-Oct-2026IST
Market cap
₹6,773 Cr
Revenue (TTM)
₹1,951 Cr
P/E Ratio
48.2
P/B Ratio
5.2
Div. Yield
0.2 %
Quality Score
1/10
Growth Score
6/10
Valuation Score
2/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹141 Cr
-
ROE
8 %
-
ROCE
10.2 %
-
Industry P/E
50.78
-
EV/EBITDA
33.5
-
Debt to Equity
0.2
-
Book Value
₹23.8
-
EPS
₹2.1
-
Face value
2
-
Shares outstanding
547,953,699
10 Years Aggregate
CFO
₹170.02 Cr
EBITDA
₹1,055.18 Cr
Net Profit
₹663.55 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Morepen Lab
| 201.6 | 16.6 | 102.3 | 157.6 | 51.5 | 17.8 | 18.2 |
|
BSE Healthcare
| 11.1 | -4.4 | -4.3 | 8.5 | 19.5 | 12.8 | 11.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Morepen Lab
| -48.1 | 59.2 | 28.3 | -32.7 | 84.7 | 95.5 | -29.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Morepen Lab
|
123.9 | 6,772.7 | 1,950.6 | 140.6 | 7.6 | 9.6 | 48.2 | 5.2 |
| 1,309.5 | 16,072.6 | 2,590.4 | 603.0 | 29.3 | 19.6 | 26.7 | 4.6 | |
| 520.7 | 9,837.6 | 885.7 | 234.9 | 27.8 | 18 | 41.9 | 4.4 | |
| 1,339.0 | 14,003.4 | 1,108.4 | 270.2 | 28.3 | 14.5 | 50.9 | 6.8 | |
| 1,820.6 | 34,586.2 | 9,683.5 | 1,019.0 | 15.7 | 21.3 | 34.2 | 6.6 | |
| 194.7 | 5,719.4 | 2,523.6 | 168.1 | 9.1 | 9.9 | 34 | 3.1 | |
| 19,675.0 | 25,274.5 | 2,371.8 | 497.8 | 28.0 | 28.5 | 50.8 | 12.5 | |
| 1,318.4 | 6,057.7 | 691.7 | 130.8 | 24.5 | 14.5 | 47.9 | 6.3 | |
| 1,000.7 | 11,301.1 | 675.6 | 183.6 | 32.2 | 22.7 | 61.9 | 12.2 | |
| 303.6 | 8,582.8 | 8.8 | -352.4 | -4,228.0 | -80.8 | -- | 15.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By News Desk
About Morepen Lab
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for... anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, NASH/ MASH treatment products, CKD treatment, and anti-depressant drugs; and home diagnostic and point-of-care medical devices products, such as blood glucose monitor and test strips, blood pressure monitors, respiratory devices, ortho support, digital thermometers, digital weighing scale, fertility, nebulizers, pulse oximeters, vaporizers, orthopaedic, stethoscope, and miscellaneous products. It also provides OTC healthcare products; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. In addition, the company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India. Read more
-
Incorporated
1984
-
Chairman
Sushil Suri
-
Managing Director
Sushil Suri
-
Group
Morepen
-
Headquarters
Solan Dist, Himachal Pradesh
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Morepen Lab
What is the current share price of Morepen Laboratories Ltd Today?
The share price of Morepen Laboratories Ltd is ₹123.87 (NSE) and ₹123.60 (BSE) as of 16-Oct-2026 IST. Morepen Laboratories Ltd has given a return of 51.53% in the last 3 years.
What is the current PB & PE ratio of Morepen Laboratories Ltd?
The P/E ratio of Morepen Laboratories Ltd is 48.19 times as on 16-Oct-2026, a 5 discount to its peers’ median range of 50.78 times.
The P/B ratio of Morepen Laboratories Ltd is 5.20 times as on 16-Oct-2026, a 49 premium to its peers’ median range of 3.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
19.52 |
1.49 |
2025 |
22.21 |
2.27 |
2024 |
22.36 |
2.54 |
2023 |
33.94 |
1.74 |
2022 |
17.20 |
3.17 |
What is the 52 Week High and Low of Morepen Laboratories Ltd?
The 52-week high and low of Morepen Laboratories Ltd are Rs 150.70 and Rs 33.05 as of 19-Oct-2026.
What is the market cap of Morepen Laboratories Ltd?
Morepen Laboratories Ltd has a market capitalisation of ₹ 6,773 Cr as on 16-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Morepen Laboratories Ltd?
Before investing in Morepen Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.